For the quarter ending 2025-09-30, GMED made $769,048,000 in revenue. $119,654,000 in net income. Net profit margin of 15.56%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net sales | 769,048,000 | 745,342,000 | 598,121,000 | 631,979,500 |
| Cost of sales (exclusive of amortization of intangibles) | 252,533,000 | 248,765,000 | 195,397,000 | 244,448,666.667 |
| Research and development | 38,067,000 | 39,954,000 | 33,062,000 | 45,338,000 |
| Selling, general and administrative | 313,597,000 | 303,622,000 | 242,799,000 | 251,095,500 |
| Provision for litigation, net | - | - | - | -172,500 |
| Amortization of intangibles | 29,843,000 | 30,189,000 | 28,802,000 | 29,794,000 |
| Acquisition-related costs | -2,713,000 | 33,156,000 | 1,057,000 | 9,753,000 |
| Restructuring costs | 358,000 | 13,547,000 | - | 9,574,000 |
| Operating income/(loss) | 137,363,000 | 76,109,000 | 97,004,000 | 26,122,166.667 |
| Interest income/(expense), net | 1,455,000 | 693,000 | 1,681,000 | 5,954,833.333 |
| Foreign currency transactional gain/(loss) | -161,000 | 38,000 | 4,270,000 | -26,430,500 |
| Bargain purchase gain | 3,800,000 | 110,561,000 | - | - |
| Other income/(expense) | 1,537,000 | 772,000 | 713,000 | 2,408,000 |
| Total other income/(expense), net | 6,631,000 | 112,064,000 | 6,664,000 | -18,067,666.667 |
| Income/(loss) before income taxes | 143,994,000 | 188,173,000 | 103,668,000 | 8,054,500 |
| Income tax provision/(benefit) | 25,028,000 | -14,673,000 | 28,206,000 | -1,639,500 |
| Net income/(loss) | 118,966,000 | 202,846,000 | 75,462,000 | 9,694,000 |
| Unrealized gain/(loss) on marketable securities | 30,000 | 2,000 | 315,000 | 70,500 |
| Foreign currency translation gain/(loss) | 658,000 | 12,404,000 | 4,379,000 | -446,000 |
| Total other comprehensive income/(loss), net of tax | 688,000 | 12,406,000 | 4,694,000 | -375,500 |
| Comprehensive income/(loss) | 119,654,000 | 215,252,000 | 80,156,000 | 9,318,500 |
| Earnings per share, basic | 0.88 | 1.5 | 0.55 | 0.075 |
| Earnings per share, diluted | 0.88 | 1.49 | 0.54 | 0.07 |
| Weighted average number of shares outstanding, basic | 134,502,000 | 135,205,000 | 136,757,000 | -67,542,000 |
| Weighted average number of shares outstanding, diluted | 135,394,000 | 136,499,000 | 139,774,000 | -68,589,000 |
GLOBUS MEDICAL INC (GMED)
GLOBUS MEDICAL INC (GMED)